LQDA - Liquidia Corp Qarzning balans kapitallashuviga nisbati

Liquidia Corp (LQDA) grafik logotipi

Liquidia Corporation (LQDA) narxlarining trayektoriyasi og'ir bemorlar holatini yengillatish uchun ilg'or dori yetkazib berish usullarini ishlab chiqayotgan biofarmatsevtika innovatori dinamikasini aks ettiradi. Liquidia Corporation o'pka arterial gipertenziyasi uchun inhalatsiya terapiyalarini ishlab chiqmoqda, bu esa 0.87 darajasida yuqori daromadlilik va barqaror FCF ni ta'minlaydi. Biznes AQSh huquqiy bazasiga tayanadi va o'z ishlanmalarining gumanitar maqomi tufayli sanksiyalar hamda tashqi siyosiy zarbalardan himoyalangan holda qolmoqda.

LQDA (Liquidia Inc.) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 28.10.2026gacha

Liquidia Corp (LQDA) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Liquidia Corporation|LQDA - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Liquidia Inc.|LQDA - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Liquidia|LQDA - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati liquidia.com|LQDA - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Liquidia Corporation|LQDA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Liquidia Technologies|LQDA - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Liquidia Inc.|LQDA - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzlari Liquidia
Kompaniyaning barcha koʻrsatkichlari tahlili:LQDA Liquidia Corporation
Liquidia Technologies asosiy tovari

Ushbu ko'rsatkich umumiy qarzdorlikni aksiyalar kapitalining bozor qiymati bilan kunlik asosda bog'lagan holda moliyaviy leveraj darajasini o'lchaydi. Kompaniyaning moliyaviy leveraj trayektoriyasini tahlil qilish orqali investor to'lov qobiliyatining yo'qolishi xavfi va kengayish uchun resurslar o'rtasidagi muvozanatni baholaydi, bu esa pulmonar gipertenziya terapiyasi segmentida yetakchilik uchun uzoq davom etayotgan patent nizolari fonida Liquidia Corporation (LQDA) uchun o'ta muhimdir.

Liquidia Corporation raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Verona Pharma (VRNA)|MENS: Qarzning sof aktivlarga nisbati|LGND (Ligand Pharma) - Qarzning balans kapitallashuviga nisbati|Amneal Corp (AMRX) - Qarzning balans qiymatiga nisbati|PRGO (Perrigo Company plc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar alvotech.com (ALVO)|Galapagos (GLPG) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati ANIP (ANI Pharmaceuticals Inc)|MNKD: Qarzning balans kapitallashuviga nisbati|AMPH - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Pacira BioSciences PCRX|SPRY - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar Theravance Biopharma, Inc. TBPH|Aquestive Therapeutics Inc (AQST) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar SCPH (scPharmaceuticals, Inc.)|Balans qiymatiga qarzlar TECX|Tonix Pharmaceuticals (TNXP) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati SXTC (sxtchina.com)|Qarzning balans kapitallashuviga nisbati Eupraxia Pharmaceuticals Inc. EPRX|Qarzning balans kapitallashuviga nisbati BioHarvest Sciences, Inc. BHST|Balans kapitallashuviga qarzlar EXOZ (Invizyne Technologies, Inc.)|ORMP: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati ENTX (enterabio.com)|Qarzning sof aktivlarga nisbati ipatherapeutics.com|ABVC (ABVC BioPharma, Inc.) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Cumberland Pharmaceuticals Inc|QNTM (Quantum BioPharma Limited) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar FibroGen Corporation (FGEN)|TELO - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Rani Therapeutics Holdings RANI|Balans kapitallashuviga qarzlar SNYR (Synergy CHC Corporation)|RLYB - Sof aktivlarga qarzlar|LEXX: Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Pulmatrix Corporation|PTHL - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Aptorum|Balans kapitallashuviga qarzlar LYRA (Lyra Therapeutics)|Qarzning balans qiymatiga nisbati IBO (Impact BioMedical, Inc.)|TNFA: Qarzning balans kapitallashuviga nisbati|cbdMD Inc. - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati PainReform Ltd. (PRFX)|CYTO: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Lipella Pharmaceuticals, Inc. (LIPO)|OPTN (OptiNose Inc) - Qarzlarning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati PIRS (Pieris)|Balans qiymatiga qarzlar PROC|Petros Pharmaceuticals (PTPI) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati qlsyy.net (QLI)|Balans kapitallashuviga qarzlar SLRN (ACELYRIN)|TFFP - Balans kapitallashuviga qarzlar